Activities, Bill Numbers and Titles
|
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Support
|
$632.40
|
N/A
|
Senate Bill
|
1539
|
An Act requiring health care employers to develop and implement programs to prevent workplace violence
|
Support
|
$316.20
|
N/A
|
House Bill
|
1250
|
An Act to advance health equity
|
Support
|
$1,264.80
|
N/A
|
House Bill
|
2330
|
An Act requiring health care employers to develop and implement programs to prevent workplace violence
|
Support
|
$316.20
|
N/A
|
Senate Bill
|
799
|
An Act to advance health equity
|
Support
|
$1,264.80
|
N/A
|
House Bill
|
4601
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$632.40
|
N/A
|
House Bill
|
648
|
An Act to improve quality and oversight of long-term care
|
Support
|
$1,264.80
|
N/A
|
House Bill
|
1981
|
An Act relative to preventing overdose deaths and increasing access to treatment
|
Support
|
$1,264.80
|
N/A
|
House Bill
|
4643
|
An Act enhancing the market review process
|
Support
|
$632.40
|
N/A
|
House Bill
|
649
|
An Act to improve Massachusetts home care
|
Support
|
$632.40
|
N/A
|
Senate Bill
|
2800
|
An Act making appropriations for the fiscal year 2025 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements
|
Neutral
|
$632.40
|
N/A
|
| | |
Total amount
|
$8,853.60
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
12/31/2024
|
12/31/2024
|
JAMES WILMUTH
|
PARKING AND RELATED EXPENSES
|
$100.00
|
| | | Total amount |
$100.00
|
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|